178 related articles for article (PubMed ID: 28472814)
1. PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies.
Luan T; Hua Q; Liu X; Xu P; Gu Y; Qian H; Yan L; Xu X; Geng R; Zeng X; Li P
Int J Gynecol Cancer; 2017 Sep; 27(7):1480-1488. PubMed ID: 28472814
[TBL] [Abstract][Full Text] [Related]
2. PAX1 and SOX1 Gene Methylation as a Detection and Triage Method for Cervical Intraepithelial Neoplasia Diagnosis.
Gao Y; Zi D; Liang W; Qiu F; Zheng J; Xiao X; Jiang E; Xu Y
Acta Cytol; 2024; 68(2):137-144. PubMed ID: 38527422
[TBL] [Abstract][Full Text] [Related]
3. PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis.
Nikolaidis C; Nena E; Panagopoulou M; Balgkouranidou I; Karaglani M; Chatzaki E; Agorastos T; Constantinidis TC
Cancer Epidemiol; 2015 Oct; 39(5):682-6. PubMed ID: 26234429
[TBL] [Abstract][Full Text] [Related]
4. Real time quantitative methylation detection of PAX1 gene in cervical cancer screening.
Liu H; Meng X; Wang J
Int J Gynecol Cancer; 2020 Oct; 30(10):1488-1492. PubMed ID: 32616628
[TBL] [Abstract][Full Text] [Related]
5. The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer.
Liang H; Li GL; Liu J; Fu M; Huang H; Zhao K; Wei Y; Xiao J
Clin Transl Oncol; 2021 Feb; 23(2):283-288. PubMed ID: 32514824
[TBL] [Abstract][Full Text] [Related]
6. Real-time colorimetric detection of DNA methylation of the
Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
[TBL] [Abstract][Full Text] [Related]
8. PAX1 methylation as a potential biomarker for cervical cancer screening.
Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
10. Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
Ki EY; Lee KH; Hur SY; Rhee JE; Kee MK; Kang C; Park JS
Int J Gynecol Cancer; 2016 Jan; 26(1):176-83. PubMed ID: 26552048
[TBL] [Abstract][Full Text] [Related]
11. PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.
Lai HC; Ou YC; Chen TC; Huang HJ; Cheng YM; Chen CH; Chu TY; Hsu ST; Liu CB; Hung YC; Wen KC; Yu MH; Wang KL
Cancer Med; 2014 Aug; 3(4):1062-74. PubMed ID: 24799352
[TBL] [Abstract][Full Text] [Related]
12. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.
Xu J; Xu L; Yang B; Wang L; Lin X; Tu H
Int J Clin Exp Pathol; 2015; 8(2):1674-81. PubMed ID: 25973053
[TBL] [Abstract][Full Text] [Related]
13. Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.
Chang CC; Huang RL; Liao YP; Su PH; Hsu YW; Wang HC; Tien CY; Yu MH; Lin YW; Lai HC
BMC Cancer; 2015 May; 15():418. PubMed ID: 25985991
[TBL] [Abstract][Full Text] [Related]
14. PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions.
Wang ZM
Asian Pac J Cancer Prev; 2014; 15(2):891-4. PubMed ID: 24568514
[TBL] [Abstract][Full Text] [Related]
15. PAX1 Methylation Hallmarks Promising Accuracy for Cervical Cancer Screening in Asians: Results from a Meta-Analysis.
Kong LY; Du W; Wang L; Yang Z; Zhang HS
Clin Lab; 2015; 61(10):1471-9. PubMed ID: 26642709
[TBL] [Abstract][Full Text] [Related]
16. High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma.
Chang CC; Huang RL; Wang HC; Liao YP; Yu MH; Lai HC
Int J Gynecol Cancer; 2014 Feb; 24(2):201-9. PubMed ID: 24407576
[TBL] [Abstract][Full Text] [Related]
17. Value of PAX1 Methylation Analysis by MS-HRM in the Triage of Atypical Squamous Cells of Undetermined Significance.
Li SR; Wang ZM; Wang YH; Wang XB; Zhao JQ; Xue HB; Jiang FG
Asian Pac J Cancer Prev; 2015; 16(14):5843-6. PubMed ID: 26320460
[TBL] [Abstract][Full Text] [Related]
18. IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer.
Lu D; Yang X; Jiang NY; Woda BA; Liu Q; Dresser K; Mercurio AM; Rock KL; Jiang Z
Am J Surg Pathol; 2011 Nov; 35(11):1638-45. PubMed ID: 21997684
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia.
Lendvai Á; Johannes F; Grimm C; Eijsink JJ; Wardenaar R; Volders HH; Klip HG; Hollema H; Jansen RC; Schuuring E; Wisman GB; van der Zee AG
Epigenetics; 2012 Nov; 7(11):1268-78. PubMed ID: 23018867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
